Preclinical proof of concept for the first Nanocyclix TKI-PET radiotracer targeting activated EGFR positive lung tumors

被引:4
|
作者
Genne, Philippe
Berthet, Cyril
Raguin, Olivier
Chalon, Sylvie
Tizon, Xavier
Serriere, Sophie
Provent, Peggy
de Boisferon, Marc Hillairet
Vercouillie, Johnny
Mothes, Celine
Gourand, Fabienne
Barre, Louisa
Guilloteau, Denis
Blom, Petra
Hoflack, Jan
机构
关键词
D O I
10.1158/1538-7445.AM2017-1875A
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1875A
引用
下载
收藏
页数:2
相关论文
共 3 条
  • [1] Radiosynthesis of the first [18F]-Nanocyclix® TKI-PET radiotracer targeting activated EGFR positive lung tumors
    Mothes, Celine
    Viot, Gilles
    Vala, Christine
    Raguin, Olivier
    Provent, Peggy
    Collin, Bertrand
    Oudot, Alexandra
    Guilloteau, Denis
    Hoflack, Jan
    Berthet, Cyril
    Blom, Petra
    Vercouillie, Johnny
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2017, 60 : S350 - S350
  • [2] Development of [18F]afatinib as new TKI-PET tracer for EGFR positive tumors
    Slobbe, Paul
    Windhorst, Albert D.
    Stigter-van Walsum, Marijke
    Schuit, Robert C.
    Smit, Egbert F.
    Niessen, Heiko G.
    Solca, Flavio
    Stehle, Gerd
    van Dongen, Guus A. M. S.
    Poot, Alex J.
    NUCLEAR MEDICINE AND BIOLOGY, 2014, 41 (09) : 749 - 757
  • [3] [68Ga]Ga-DATA5m-LM4, a PET Radiotracer in the Diagnosis of SST2R-Positive Tumors: Preclinical and First Clinical Results
    Kanellopoulos, Panagiotis
    Nock, Berthold A. A.
    Greifenstein, Lukas
    Baum, Richard P. P.
    Roesch, Frank
    Maina, Theodosia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (23)